Corbus Pharmaceuticals
CRBP
CRBP
140 hedge funds and large institutions have $383M invested in Corbus Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 42 funds opening new positions, 46 increasing their positions, 27 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
26% more funds holding
Funds holding: 111 → 140 (+29)
0.47% more ownership
Funds ownership: 1.62% → 2.1% (+0.47%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
140
Holding in Top 10
1
Calls
$49.2M
Puts
$24.8M
Top Buyers
1 | +$25.5M | |
2 | +$15.9M | |
3 | +$12.6M | |
4 |
D.E. Shaw & Co
New York
|
+$6.94M |
5 |
Morgan Stanley
New York
|
+$4.79M |
Top Sellers
1 | -$5.37M | |
2 | -$1.84M | |
3 | -$1.78M | |
4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.4M |
5 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
-$1.06M |